EXHIBIT 31.1


CERTIFICATION
PURSUANT TO SECTION 302 OF THE


SARBANES-OXLEY
ACT OF 2002





I,
William F. Donovan, M.D., Chief Executive Officer of Spine Pain Management,
Inc., certify that:





1.
            I
      have reviewed this quarterly report on Form 10-Q of Spine Pain Management,
      Inc.;





2.
            Based
      on my knowledge, this report does not contain any untrue statement of a
      material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      report;





3.
            Based
      on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the issuer as
      of, and for, the periods presented in this
  report;





4.
            The
      issuer’s other certifying officer and I are responsible for establishing
      and maintaining disclosure controls and procedures (as defined in Exchange
      Act Rules 13a-15(e) and 15d-15(e)) for the issuer and
  have:





(a)
Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under my supervision, to ensure that
material information relating to the issuer, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;





(b)
Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under my supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;





(c)
Evaluated the effectiveness of the issuer's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and





(d)
Disclosed in this report any change in the issuer's internal control over
financial reporting that occurred during the issuer's most recent fiscal year
that has materially affected, or is reasonably likely to materially affect, the
issuer's internal control over financial reporting; and





5.
            The
      issuer’s other certifying officer and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      issuer's independent registered public accounting firm and the audit
      committee of the issuer's board of directors (or persons performing the
      equivalent functions):





(a) All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the issuer's ability to record, process, summarize and report
financial information; and





(b) Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the issuer's internal control over financial
reporting.




Date:
      August 16, 2010
              By:
              /s/
      William F. Donovan, M.D.William
      F. Donovan, M.D.Chief
      Executive Officer